Fallah A, et al
Flow cytometry analysis of peripheral neutrophils (CD45 + CD11b + Ly6G&Ly6C + ) and monocytes (CD45 + CD11b + Ly6G&Ly6C - ) from Gpx4 fl/fl ( c : n = 6, d : n = 10) and Gpx4 fl/wt LysMCre + (c: n = 9, d: n = 13) mice

Common side effects (minimal) Most people: No side effects GHK-Cu extremely well-tolerated Natural peptide (found in body) Minimal adverse effects Possible minor effects: Injection site stinging (common, harmless) Minor bruising at injection sites Slight blue tint to injection site (copper, temporary) Mild headache (rare) Managing side effects: Stinging: Inject slowly, warm peptide to room temp Bruising: Rotate sites, proper technique Blue tint: Normal, fades within days Headache: Hydrate well, reduce dose Contraindications and cautions Avoid if: Pregnancy or breastfeeding (no data) Active cancer (theoretical copper concerns) Wilson's disease (copper metabolism disorder) Hemochromatosis (iron overload, copper caution) Use caution with: Copper supplements (avoid taking both) High copper foods (monitor intake) Liver disease (copper metabolism) Generally safe for: All ages (adults) Men and women Long-term use Most health conditions Copper toxicity concerns Is copper in GHK-Cu dangerous

The quality control, sterility, and dosing accuracy of research peptides is not regulated and poses real safety risks
Clinical studies showing significant wrinkle reduction and skin firmness improvements have typically used formulations within this range
Evidence comparison: GHK-Cu has a substantially larger body of published research, spanning from Pickart's original 1973 isolation through hundreds of subsequent studies